Donald Goff

27.0k total citations · 3 hit papers
285 papers, 20.1k citations indexed

About

Donald Goff is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Biological Psychiatry. According to data from OpenAlex, Donald Goff has authored 285 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Psychiatry and Mental health, 84 papers in Cognitive Neuroscience and 36 papers in Biological Psychiatry. Recurrent topics in Donald Goff's work include Schizophrenia research and treatment (145 papers), Functional Brain Connectivity Studies (45 papers) and Tryptophan and brain disorders (36 papers). Donald Goff is often cited by papers focused on Schizophrenia research and treatment (145 papers), Functional Brain Connectivity Studies (45 papers) and Tryptophan and brain disorders (36 papers). Donald Goff collaborates with scholars based in United States, China and Canada. Donald Goff's co-authors include Oliver Freudenreich, David C. Henderson, A. Eden Evins, Dara S. Manoach, Guochuan Tsai, Jeffrey A. Lieberman, Corinne Cather, Joseph P. McEvoy, T. Scott Stroup and Sonia M. Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Neuroscience.

In The Last Decade

Donald Goff

281 papers receiving 19.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

2005 897 citations Donald Goff, Jeffrey A. Lieberman et al. Schizophrenia Research profile →
Regionally localized thinning of the cerebral cortex in schizophrenia

2003 696 citations Gina R. Kuperberg, Donald Goff et al. Schizophrenia Research profile →
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19

2021 239 citations Donald Goff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donald Goff United States	78	9.5k	5.5k	3.4k	2.9k	2.8k	285	20.1k
Gary Remington Canada	67	11.3k 1.2×	3.1k 0.6×	3.4k 1.0×	2.0k 0.7×	1.6k 0.6×	468	17.8k
Stefan Borgwardt Switzerland	66	7.7k 0.8×	6.7k 1.2×	4.6k 1.3×	2.2k 0.8×	1.9k 0.7×	352	23.7k
Shih‐Jen Tsai Taiwan	63	4.5k 0.5×	4.1k 0.7×	3.7k 1.1×	2.6k 0.9×	1.7k 0.6×	689	16.9k
David C. Steffens United States	81	9.2k 1.0×	4.8k 0.9×	1.5k 0.4×	1.2k 0.4×	3.4k 1.2×	406	23.4k
Glenda MacQueen Canada	70	6.8k 0.7×	4.3k 0.8×	2.7k 0.8×	1.6k 0.5×	1.4k 0.5×	270	19.4k
Thomas B. Cooper United States	74	7.7k 0.8×	3.1k 0.6×	6.0k 1.7×	2.3k 0.8×	1.3k 0.5×	342	19.5k
Richard S.E. Keefe United States	85	20.2k 2.1×	7.4k 1.3×	3.2k 0.9×	2.5k 0.9×	1.4k 0.5×	349	29.0k
Stephen R. Marder United States	74	14.2k 1.5×	3.4k 0.6×	2.3k 0.7×	1.7k 0.6×	1.1k 0.4×	319	20.5k
Oliver Howes United Kingdom	85	11.8k 1.2×	7.5k 1.4×	6.8k 2.0×	4.4k 1.5×	1.6k 0.6×	435	27.7k
Henry A. Nasrallah United States	67	9.1k 1.0×	2.6k 0.5×	1.5k 0.4×	1.3k 0.5×	1.5k 0.6×	351	15.2k

Countries citing papers authored by Donald Goff

Since Specialization

Citations

This map shows the geographic impact of Donald Goff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Goff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Goff more than expected).

Fields of papers citing papers by Donald Goff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Goff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Goff. The network helps show where Donald Goff may publish in the future.

Co-authorship network of co-authors of Donald Goff

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Goff. A scholar is included among the top collaborators of Donald Goff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Goff. Donald Goff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertisch, Hilary, et al.. (2025). Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disorders. Molecular Psychiatry. 30(6). 2739–2747. 2 indexed citations

Miller, Brian J., Henrique Lemos, Nina R. Schooler, et al.. (2023). Longitudinal study of inflammation and relapse in schizophrenia. Schizophrenia Research. 252. 88–95. 7 indexed citations

Bertisch, Hilary, Pippa Storey, Rebecca Anthopolos, et al.. (2022). Decreased basal ganglia and thalamic iron in early psychotic spectrum disorders are associated with increased psychotic and schizotypal symptoms. Molecular Psychiatry. 27(12). 5144–5153. 11 indexed citations

Bertisch, Hilary, Hong‐Hsi Lee, Pippa Storey, et al.. (2021). Quantitative Macromolecular Proton Fraction Mapping Reveals Altered Cortical Myelin Profile in Schizophrenia Spectrum Disorders. Cerebral Cortex Communications. 2(2). tgab015–tgab015. 12 indexed citations

Kantrowitz, Joshua T., Jack Grinband, Donald Goff, et al.. (2020). Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology. 45(11). 1842–1850. 35 indexed citations

Guo, Qian, Yang Hu, Botao Zeng, et al.. (2020). Parietal memory network and default mode network in first‐episode drug‐naïve schizophrenia: Associations with auditory hallucination. Human Brain Mapping. 41(8). 1973–1984. 10 indexed citations

Schoretsanitis, Georgios, John M. Kane, Christoph U. Correll, et al.. (2020). Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice. The Journal of Clinical Psychiatry. 81(3). 88 indexed citations

Roffman, Joshua L., Liana Petruzzi, Alexandra Tanner, et al.. (2017). Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial. Molecular Psychiatry. 23(2). 316–322. 45 indexed citations

Goff, Donald. (2016). D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity. Current Neuropharmacology. 15(1). 21–34. 25 indexed citations

10.

Zhuo, Kaiming, Zhiliang Yang, Xiaoduo Fan, et al.. (2012). Prospective memory performance in patients with drug-naïve, first-episode psychosis. Schizophrenia Research. 143(2-3). 285–290. 22 indexed citations

11.

Dyckman, Kara A., Adrian K. C. Lee, Yigal Agam, et al.. (2011). Abnormally persistent fMRI activation during antisaccades in schizophrenia: A neural correlate of perseveration?. Schizophrenia Research. 132(1). 62–68. 25 indexed citations

12.

Holt, Daphne J., Balaji M. Lakshmanan, Oliver Freudenreich, et al.. (2009). Dysfunction of a Cortical Midline Network During Emotional Appraisals in Schizophrenia. Schizophrenia Bulletin. 37(1). 164–176. 40 indexed citations

13.

Barton, Jason J.S., et al.. (2007). The relation between antisaccade errors, fixation stability and prosaccade errors in schizophrenia. Experimental Brain Research. 186(2). 273–282. 27 indexed citations

14.

Kuperberg, Gina R., Tatiana Sitnikova, Donald Goff, & Phillip J. Holcomb. (2006). Making sense of sentences in schizophrenia: Electrophysiological evidence for abnormal interactions between semantic and syntactic processing.. Journal of Abnormal Psychology. 115(2). 251–265. 65 indexed citations

15.

Large, Charles H., Elizabeth Webster, & Donald Goff. (2005). The potential role of lamotrigine in schizophrenia. Psychopharmacology. 181(3). 415–436. 50 indexed citations

16.

Gould, Robert A., et al.. (2004). Cognitive Therapy for Psychosis in Schizophrenia: An Effect Size Analysis. FOCUS The Journal of Lifelong Learning in Psychiatry. 2(1). 95–101. 9 indexed citations

17.

Evins, A. Eden, et al.. (2002). d-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophrenia Research. 56(1-2). 19–23. 96 indexed citations

18.

Goff, Donald, Leslie Leahy, Ileana Berman, et al.. (2001). A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia. Journal of Clinical Psychopharmacology. 21(5). 484–487. 167 indexed citations

19.

Evins, A. Eden, et al.. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research. 3(4). 397–403. 157 indexed citations

20.

Evins, A. Eden, et al.. (1997). Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. Journal of Neural Transmission. 104(6-7). 761–766. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact